Warrant Amendment Agreement between Baudax Bio, Inc. and Holder (August 24, 2022)
Baudax Bio, Inc. and the holder of certain warrants have agreed to amend the holder's existing warrants to purchase common stock. The amendment reduces the exercise price of the warrants to $0.5981 per share, effective immediately. All other terms of the original warrants remain unchanged. The company will provide amended warrant documents upon request and will file a prospectus supplement related to this amendment. Both parties have signed to confirm their agreement to these changes.
Exhibit 4.1
August 24, 2022
Holder of Warrants to Purchase Common Stock issued on [ ]
Re: Amendment to Existing Warrants
Dear Holder:
This letter confirms that Baudax Bio, Inc. (the “Company”) hereby amends, effective as of the date hereof, the Holder’s existing warrants to purchase up to ____ shares of common Stock at an exercise price of $[ ] per share issued on [ ] (collectively, the “Existing Warrants”), by reducing the Exercise Price (as defined therein) of the Existing Warrants to $0.5981 per share (the “Warrant Amendment”). The Warrant Amendment shall be effective on the date hereof.
Except as expressly set forth herein, the terms and provisions of the Existing Warrants shall remain in full force and effect after the execution of this letter and shall not be in any way changed, modified or superseded except by the terms set forth herein.
From and after the effectiveness of the Warrant Amendment, the Company agrees to promptly deliver to the Holder, upon request, amended Existing Warrants that reflect the Warrant Amendments in exchange for the surrender for cancellation of the Holder’s Existing Warrants to be amended as provided herein. In addition, the Company shall file a prospectus supplement to the applicable registration statement in connection with the amendments hereunder on the date hereof.
[Signature Page Follows]
IN WITNESS WHEREOF, the parties hereto have caused this agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
BAUDAX BIO, INC.
| By: |
| Name: | ||
| Title: |
Name of Holder: ________________________________________________________
Signature of Authorized Signatory of Holder: __________________________________
Name of Authorized Signatory: ____________________________________________________
[SIGNATURE PAGE TO [ ] BXRX WARRANT AMENDMENT AGREEMENT]
